These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND NF2, ACN, 4771, ENSG00000186575, P35240, SCH, Merlin, BANF
119 results:

  • 1. Trends in colorectal cancer screening compliance and incidence among 60- to 74-year-olds in China.
    Zhang M; Zhang Y; Guo L; Zhao L; Jing H; Yang X; Zhang W; Zhang Y; Nie Z; Zhu S; Zhang S; Zhang X
    Cancer Med; 2024 Apr; 13(8):e7133. PubMed ID: 38634216
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Performance of the Asia-Pacific colorectal Screening score in stratifying the risk of advanced colorectal neoplasia: A meta-analysis and systematic review.
    Luu MN; Trinh NA; Tran TLT; Dang TP; Hiyama T; Quach DT
    J Gastroenterol Hepatol; 2024 Jun; 39(6):1000-1007. PubMed ID: 38425009
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Prevalence and risk factors of colorectal neoplasia in individuals aged 40-49 years: Findings from screening program in China.
    Zhang M; Zhang Y; Zhang W; Zhang Y; Zhao L; Jing H; Gao X; Nie Z; Zhu S; Zhang S; Zhang X
    J Gastroenterol Hepatol; 2024 Apr; 39(4):694-700. PubMed ID: 38200678
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Acetylcorynoline Induces Apoptosis and G2/M Phase Arrest through the c-Myc Signaling Pathway in Colon cancer Cells.
    Park YR; Jee W; Park SM; Kim SW; Jung JH; Kim H; Kim KI; Jang HJ
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139419
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Risk of recurrent advanced colorectal neoplasia in individuals with baseline non-advanced neoplasia followed up at 5 vs 7-10 years.
    Wong MCS; Leung EY; Chun SCC; Deng Y; Lam T; Tang RSY; Huang J
    J Gastroenterol Hepatol; 2023 Dec; 38(12):2122-2129. PubMed ID: 37771047
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Prediction of advanced colorectal neoplasia based on metabolic parameters among symptomatic patients.
    Wong MCS; Leung EY; Chun SCC; Wang HH; Huang J
    J Gastroenterol Hepatol; 2023 Sep; 38(9):1576-1586. PubMed ID: 37403251
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. An adjusted Asia-Pacific colorectal screening score system to predict advanced colorectal neoplasia in asymptomatic Chinese patients.
    Zhang C; Zhang L; Zhang W; Guan B; Li S
    BMC Gastroenterol; 2023 Jun; 23(1):223. PubMed ID: 37386357
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Recurrence rates of advanced colorectal neoplasia (acn) in subjects with baseline acn followed up at different surveillance intervals.
    Wong MCS; Leung EY; Chun SCC; Deng Y; Lam T; Tang RSY; Huang J
    Dig Liver Dis; 2023 Dec; 55(12):1742-1749. PubMed ID: 37127494
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The potential effect of schisandrin-B combination with panitumumab in wild-type and mutant colorectal cancer cell lines: Role of apoptosis and autophagy.
    Sana-Eldine AO; Abdelgawad HM; Kotb NS; Shehata NI
    J Biochem Mol Toxicol; 2023 May; 37(5):e23324. PubMed ID: 36808796
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. FIT-based risk-stratification model effectively screens colorectal neoplasia and early-onset colorectal cancer in Chinese population: a nationwide multicenter prospective study.
    Zhao S; Wang S; Pan P; Xia T; Wang R; Cai Q; Chang X; Yang F; Gu L; He Z; Wu J; Meng Q; Wang T; Fang Q; Mou X; Yu H; Zheng J; Bai C; Zou Y; Chen D; Zou X; Ren X; Xu L; Yao P; Xiong G; Shu X; Dang T; Zhang L; Wang W; Kang S; Cao H; Gong A; Li J; Zhang H; Du Y; Li Z; Bai Y;
    J Hematol Oncol; 2022 Nov; 15(1):162. PubMed ID: 36333749
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Head-to-head comparison of a risk-adapted screening strategy using various risk prediction models in detecting colorectal neoplasm.
    Lu M; Zhang Y; Cai J; Lu B; Luo C; Chen H; Dai M
    J Gastroenterol Hepatol; 2022 Jul; 37(7):1244-1252. PubMed ID: 35263809
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Spectrum of Advanced colorectal Neoplasia and Anticipated Yield of Average-Risk Screening in Veterans Under Age 50.
    Yen T; Scolaro J; Montminy E; Karlitz JJ; Wani S; Patel SG;
    Clin Gastroenterol Hepatol; 2023 Mar; 21(3):827-829.e3. PubMed ID: 34800736
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Multivariable models for advanced colorectal neoplasms in screen-eligible individuals at low-to-moderate risk of colorectal cancer: towards improving colonoscopy prioritization.
    Murthy SK; Antonova L; Dube C; Benchimol EI; Le Gal G; Hae R; Burke S; Ramsay T; Rostom A
    BMC Gastroenterol; 2021 Oct; 21(1):383. PubMed ID: 34663234
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Molecular Characterization of Peritoneal Mesotheliomas.
    Offin M; Yang SR; Egger J; Jayakumaran G; Spencer RS; Lopardo J; Nash GM; Cercek A; Travis WD; Kris MG; Ladanyi M; Sauter JL; Zauderer MG
    J Thorac Oncol; 2022 Mar; 17(3):455-460. PubMed ID: 34648949
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The classification capability of the Asia Pacific colorectal Screening score in Korea: an analysis of the cancer Screenee Cohort.
    Luu XQ; Lee K; Kim J; Sohn DK; Shin A; Choi KS
    Epidemiol Health; 2021; 43():e2021069. PubMed ID: 34607403
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Comparison of multiple statistical models for the development of clinical prediction scores to detect advanced colorectal neoplasms in asymptomatic Thai patients.
    Soonklang K; Siribumrungwong B; Siripongpreeda B; Auewarakul C
    Medicine (Baltimore); 2021 May; 100(20):e26065. PubMed ID: 34011125
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Comparative effectiveness of five fecal immunochemical tests using colonoscopy as the gold standard: study protocol.
    Levy BT; Daly JM; Xu Y; Crockett SD; Hoffman RM; Dawson JD; Parang K; Shokar NK; Reuland DS; Zuckerman MJ; Levin A
    Contemp Clin Trials; 2021 Jul; 106():106430. PubMed ID: 33974994
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Risk Stratification Score Improves Sensitivity for Advanced colorectal Neoplasia in colorectal cancer Screening: The Oshima Study Workgroup.
    Sekiguchi M; Kakugawa Y; Ikematsu H; Hotta K; Konda K; Tanaka Y; Takamaru H; Yamada M; Sakamoto T; Saito Y; Imai K; Ito S; Koga Y; Iwasaki M; Murakami Y; Matsuda T
    Clin Transl Gastroenterol; 2021 Mar; 12(3):e00319. PubMed ID: 33939384
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Risk of metachronous neoplastic lesions during post-polypectomy surveillance in individuals with advanced colorectal neoplasia at initial screening colonoscopy.
    Sekiguchi M; Kakugawa Y; Takamaru H; Yamada M; Sakamoto T; Saito Y; Matsuda T
    J Gastroenterol Hepatol; 2021 Aug; 36(8):2230-2238. PubMed ID: 33626598
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Role and mechanism of autophagy-regulating factors in tumorigenesis and drug resistance.
    Usman RM; Razzaq F; Akbar A; Farooqui AA; Iftikhar A; Latif A; Hassan H; Zhao J; Carew JS; Nawrocki ST; Anwer F
    Asia Pac J Clin Oncol; 2021 Jun; 17(3):193-208. PubMed ID: 32970929
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 6.